Article Text
Editorial commentary
Motor unit gains in treated spinal muscular atrophy patients
Statistics from Altmetric.com
Footnotes
Contributors Both authors contributed equally to the conception, writing and editing of this editorial.
Funding The authors have declared a specific grant from a public funding agency.
Competing interests CJS has been a consultant to Biogen, Ionis Pharmaceuticals, Roche/Genetech, PTC Therapeutics, and AveXis Pharmaceuticals. CS receives grant support from Roche.
Patient consent for publication Not required.
Provenance and peer review Commissioned; internally peer reviewed.